HomePharma

Pharma

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Life Sciences Times - April 30, 2026

Pharma

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

Life Sciences Times - April 30, 2026

Pharma

Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment

Life Sciences Times - April 30, 2026

Pharma

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

Life Sciences Times - April 29, 2026

Pharma

FDA Accepts New Drug Application for Zipalertinib in EGFR-Mutated Lung Cancer

Life Sciences Times - April 28, 2026

Pharma

908 Devices Announces Launch of Initial Public Offering

Life Sciences Times - December 14, 2020 0

Pharma

Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19

Life Sciences Times - December 12, 2020 0

Pharma

Trastuzumab Deruxtecan Recommended for Approval in the EU by CHMP for HER2 Positive Metastatic Breast Cancer

Life Sciences Times - December 11, 2020 0

Pharma

Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis

Life Sciences Times - December 10, 2020 0

Medtech

SciNeuro Pharmaceuticals Launches to Bring Innovative Treatments for CNS Diseases

Life Sciences Times - December 8, 2020 0

1...89 9091Page 91 of 91

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

April 30, 2026

Johnson & Johnson Names Ryan Koors Vice President of Investor Relations

April 30, 2026

Moleculent Raises $20 Million to Expand Functional Profiling Platform

April 30, 2026

Komodo Health Names Paul Thomas Chief Financial Officer

April 30, 2026

Pharma

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

FDA Accepts New Drug Application for Zipalertinib in EGFR-Mutated Lung Cancer

Most Read

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Johnson & Johnson Names Ryan Koors Vice President of Investor Relations

Moleculent Raises $20 Million to Expand Functional Profiling Platform

Komodo Health Names Paul Thomas Chief Financial Officer

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

PCI Pharma Services Unveils $1 Billion Expansion to Boost U.S. Drug Manufacturing Capabilities

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer

POPULAR CATEGORY

ABOUT US

FOLLOW US